EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing

Yasemin Coşgun, Süleyman Yalçın, Ege Dedeoğlu, Gültekin Ünal, Katharina Kopp, Biran Musul, Ekrem Sağtaş, Philomena Raftery, Gülay Korukluoğlu, Sedat Kaygusuz

Microbial Genomics · 2025

DOI: 10.1099/mgen.0.001357 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbial Genomics, 2025. Verfasst von Yasemin Coşgun und 9 weiteren Autor:innen. Beteiligte Einrichtung: The National Virology Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Türkiye. Hauptthemen laut MEDLINE: SARS-CoV-2, Genome, Viral, COVID-19, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Delegation of the European Union to Türkiye.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the COVID-19 pandemic, next-generation sequencing (NGS) has been instrumental for public health laboratories in tracking severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations and informing responses. Illumina systems and Oxford Nanopore Technologies (ONT) have been primary tools for NGS, each presenting unique advantages. The hybrid assembly (HA) approach, integrating short- and long-read sequencing methods, has been developed to improve genome accuracy by utilizing the combined advantages of both techniques. While HA has been used to enhance SARS-CoV-2 genome quality, its optimal applications for SARS-CoV-2 sequencing and surveillance have not been systematically studied. This study seeks to address this gap by evaluating the conditions under which HA improves SARS-CoV-2 genomic surveillance, analysing 192 samples using eight bioinformatics methods across both platforms. HA was evaluated against single-technology approaches for its genome assembly and mutation detection performance. While HA did not outperform single-technology methods in detecting unique mutations, it produced marginally more complete genomes than Illumina-based methods. Importantly, mutations identified by HA were consistently detected across all eight methodologies, demonstrating its reliability in mutation detection. Moreover, our research underlines the critical need for in-house validation of methods and exposes the limitations inherent in proprietary pipelines. Our findings suggest that an HA approach could be used as a quality control tool in genomic surveillance, particularly for improving low-quality ONT sequencing data by integrating high-quality Illumina sequencing data. However, implementing HA demands the presence of both sequencing platforms and additional resources, such as hands-on time, expensive sequencing reagents and bioinformatics know-how. A decision-tree analysis identified the percentage of trimmed ONT reads relative to total reads as crucial for HA success, emphasizing the significance of high-quality ONT reads. This comprehensive approach provides public health laboratories insights to refine genomic surveillance strategies for SARS-CoV-2, potentially influencing future research and response efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Genome, ViralCOVID-19High-Throughput Nucleotide SequencingPublic Health SurveillanceHumansMutationWhole Genome SequencingComputational Biology

Stichwörter der Autor:innen

IlluminaOxford Nanopore TechnologiesSARS-CoV-2genomic surveillancehybrid assembly

Autor:innen und Institutionen

  • The National Virology Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
  • The Department of National Reference Laboratories and Biological Products, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
  • Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
  • The National Molecular Microbiology Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
  • World Health Organization Country Office in Türkiye, Ankara, Türkiye.
  • World Health Organization Country Office in Türkiye, Ankara, Türkiye, from January 2022 to May 2023.

Förderung

  • World Health Organization
  • Delegation of the European Union to Türkiye

Zitieren

APA

Coşgun, Y., Yalçın, S., Dedeoğlu, E., Ünal, G., Kopp, K., Musul, B., Sağtaş, E., Raftery, P., Korukluoğlu, G., & Kaygusuz, S. (2025). Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing. Microbial Genomics. https://doi.org/10.1099/mgen.0.001357

Vancouver

Coşgun Y, Yalçın S, Dedeoğlu E, Ünal G, Kopp K, Musul B, et al. Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing. Microbial Genomics. 2025. doi:10.1099/mgen.0.001357

BibTeX
@article{Cogun2025,
  author = {Coşgun, Yasemin and Yalçın, Süleyman and Dedeoğlu, Ege and Ünal, Gültekin and Kopp, Katharina and Musul, Biran and Sağtaş, Ekrem and Raftery, Philomena and Korukluoğlu, Gülay and Kaygusuz, Sedat},
  title = {Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing},
  journal = {Microbial Genomics},
  year = {2025},
  doi = {10.1099/mgen.0.001357}
}
Kostenlos starten →